The Ghana National Biosafety Authority (NBA) recently greenlit the commercial use of 14 innovative genetically modified (GM) products, including eight maize and six soybean varieties.

This pivotal move underscores Ghana's commitment to leveraging biotechnology to bolster its agricultural domain, addressing the needs for local consumption, nutritional enhancement, and export potential.

These GM products have been sanctioned for a range of applications across food production, livestock feed, and industrial uses, highlighting the transformative potential of such biotechnological innovations.

This development is in line with Ghana's overarching strategy to adopt biotechnology responsibly, aiming for sustainable agricultural progress and economic prosperity.

This advancement builds on the NBA's approval in 2022 for the environmental release of a GM cowpea variant, engineered to withstand the Maruca pod borer—a pest notorious for decimating more than half of the cowpea yield without intervention.

The GM cowpea variety stands out for its reduced need for chemical pesticides, offering a robust alternative for farmers and bolstering agricultural resilience.

The United States Department of Agriculture has commended Ghana for its steadfast approach to adopting scientifically validated, cutting-edge technologies as part of a comprehensive plan to tackle food security challenges, particularly those exacerbated by climate change.

Despite a four-month delay, Ghana's authorisation of 14 new biotech events in late February 2024 reaffirms its status as a frontrunner in Sub-Saharan Africa, aligning policy with science.

This decision has been met with approval from the international scientific community anticipated to positively influence trade dynamics and contribute to food security.